US Broker Ratings

IDEAYA Biosciences, Inc. (IDYA): Investor Outlook on a Potential 34.8% Upside in Biotechnology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of the biotechnology sector with its focus on precision medicine oncology. The company, headquartered in South San Francisco, California, is developing..

Bausch Health (BHC) Stock Analysis: A 32.98% Upside Potential Amidst Strategic Restructuring

Bausch Health Companies Inc. (NYSE: BHC) stands out in the healthcare sector with a market capitalization of $2.11 billion. Known for its diversified pharmaceutical and medical device portfolio, Bausch Health..

Zai Lab Limited (ZLAB) Stock Analysis: Navigating Potential Upside with Strong Buy Ratings and Strategic Collaborations

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, continues to capture investor attention with its strategic focus on oncology, immunology, neuroscience, and infectious diseases. With a..

SS Innovations International (SSII) Stock Analysis: A 112.77% Potential Upside Opportunity in the Medical Devices Sector

SS Innovations International Inc. (SSII) is making waves in the healthcare sector, particularly within the medical devices industry. With its operations spanning across India and several international markets, the company..

Sotera Health Company (SHC) Stock Analysis: Exploring a 21.51% Potential Upside in the Healthcare Sector

As an investor in the burgeoning healthcare sector, Sotera Health Company (NYSE: SHC) presents a compelling opportunity. With its current market capitalization standing at $5.34 billion, Sotera Health specializes in..

Alphatec Holdings, Inc. (ATEC): Investor Outlook Reveals a Promising 55% Upside Potential

Alphatec Holdings, Inc. (NASDAQ: ATEC), a dynamic player in the healthcare sector, specifically within the medical devices industry, is carving a niche in the surgical treatment of spinal disorders. With..

Twist Bioscience Corporation (TWST) Stock Analysis: Understanding the Market Dynamics Behind the Biotech Innovator

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the biotechnology sector with its innovative approach to synthetic DNA-based products. Headquartered in South San Francisco, California, Twist Bioscience is at..

Warby Parker Inc. (WRBY) Stock Analysis: Uncovering a 31% Potential Upside for Investors

Warby Parker Inc. (NYSE: WRBY) has made significant strides in the healthcare sector, specifically in the dynamic industry of medical instruments and supplies. As a pioneer in the eyewear market,..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a Potential 127% Upside

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company based in Zug, Switzerland, is garnering significant attention from investors due to its promising therapeutic developments and substantial potential upside. Despite its..

Veracyte, Inc. (VCYT) Stock Analysis: 40.70% Potential Upside Sparks Investor Interest

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector, is capturing attention with its robust diagnostics and research capabilities. Headquartered in South San Francisco, California, Veracyte specializes in..

Organon & Co. (OGN) Stock Analysis: Navigating a Challenging Landscape with Strategic Potential

Organon & Co. (NYSE: OGN), a healthcare stalwart focusing on women’s health solutions, presents a complex yet intriguing investment proposition. The company, with a market capitalization of $3.59 billion, operates..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Growth Story with 126% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS), a Netherlands-based biotech firm, is making waves in the healthcare sector with its promising research in cardiometabolic diseases. With a market cap of $2.7 billion,..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a 76% Potential Upside in Biotech Innovation

Denali Therapeutics Inc. (NASDAQ: DNLI), a pivotal player in the biotechnology industry, is making significant strides in the healthcare sector with its robust pipeline targeting neurodegenerative and lysosomal storage diseases...

Acadia Healthcare (ACHC): Investor Outlook with 18.33% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a prominent player in the healthcare sector, specializing in behavioral healthcare services across the United States and Puerto Rico. Despite the challenging market..

Ascentage Pharma (AAPG) Stock Analysis: A 197% Potential Upside for Bold Investors

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating cancer and chronic diseases. Headquartered in..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 53% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a key player in the biotechnology industry, offers a compelling investment opportunity, particularly for those interested in healthcare innovations. With a market capitalization of $2.03 billion,..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 112% Upside Potential with Strong Buy Ratings

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing the attention of investors with its substantial potential for growth. With..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 35% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with its potential upside of 35.05%. As the company navigates the..

Surgery Partners, Inc. (SGRY) Stock Analysis: Analyst Ratings Suggest a Potential 37.76% Upside

Surgery Partners, Inc. (NASDAQ: SGRY) stands as a pivotal player in the U.S. healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.79 billion, the..

PROCEPT BioRobotics (PRCT) Stock Analysis: Navigating a 16.89% Upside Potential in the Growing Medical Device Sector

Investors eyeing the healthcare sector and, more specifically, the medical device industry, may find PROCEPT BioRobotics Corporation (NASDAQ: PRCT) an intriguing opportunity. With its focus on surgical robotics and innovative..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds